Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice.
about
Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2A diet rich in high-glucoraphanin broccoli interacts with genotype to reduce discordance in plasma metabolite profiles by modulating mitochondrial functionThe Nrf2/HO-1 Axis in Cancer Cell Growth and ChemoresistanceKeap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolismInterplay between cytosolic disulfide reductase systems and the Nrf2/Keap1 pathwayA perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomicsEmerging roles of Nrf2 signal in non-small cell lung cancerWhen NRF2 talks, who's listening?Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disordersThe complexity of the Nrf2 pathway: beyond the antioxidant responseGrowth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in miceMechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative diseaseThe clinical potential of influencing Nrf2 signaling in degenerative and immunological disordersGlucose availability is a decisive factor for Nrf2-mediated gene expressionIdentification of modulators of the nuclear receptor peroxisome proliferator-activated receptor α (PPARα) in a mouse liver gene expression compendiumThe transcriptional response to oxidative stress during vertebrate development: effects of tert-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxinNrf2: friend or foe for chemoprevention?Low-Dose Dose-Response for In Vitro Nrf2-ARE Activation in Human HepG2 CellsRole of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy.Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene.Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver.Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implicationsProteomic analysis shows synthetic oleanane triterpenoid binds to mTORSulforaphane protects Microcystin-LR-induced toxicity through activation of the Nrf2-mediated defensive responseNRF2 and cancer: the good, the bad and the importance of context.Visualization of the Drosophila dKeap1-CncC interaction on chromatin illumines cooperative, xenobiotic-specific gene activation.Nrf2 affects the efficiency of mitochondrial fatty acid oxidation.Frugal chemoprevention: targeting Nrf2 with foods rich in sulforaphaneRedox-based therapeutics in neurodegenerative disease.Genetic activation of Nrf2 protects against fasting-induced oxidative stress in livers of mice.The role of the antioxidant and longevity-promoting Nrf2 pathway in metabolic regulation.Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1.Targeting NRF2 signaling for cancer chemoprevention.Keap1-knockdown decreases fasting-induced fatty liver via altered lipid metabolism and decreased fatty acid mobilization from adipose tissueNrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice.Oral azathioprine leads to higher incorporation of 6-thioguanine in DNA of skin than liver: the protective role of the Keap1/Nrf2/ARE pathway.RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity.Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.Formation and signaling actions of electrophilic lipidsEffects of Silicon vs. Hydroxytyrosol-Enriched Restructured Pork on Liver Oxidation Status of Aged Rats Fed High-Saturated/High-Cholesterol Diets.
P2860
Q23919668-30B5488A-C919-4392-BF79-AF46D3D55856Q24631281-CCF58337-B49D-4125-81FF-FB0E39AC814BQ26772298-04001D33-DB3F-44E5-B8F5-12DA6188FA39Q26778362-921F78FF-F6F4-434E-99EF-400AD858B605Q26778366-AF1978CB-071C-4BFE-B2F4-B86249715B9EQ26852571-A0596C01-7817-4535-92E2-640861793868Q28078928-A8B69227-D2A9-4756-B7D4-53EAD01450B0Q28384223-D3ABB685-5DF8-42B2-AD5E-BD172F3BC8BAQ28384232-F76DBE1E-2B07-4FE7-85AB-D4E8B97C1A07Q28389296-A82B7DD5-93D5-4A60-8875-3C0A2B82A776Q28390350-EAA77352-1BC5-4EF1-B956-695054DBF09BQ28394732-178F05E5-E1B3-498D-8DFB-E25D55C9FE42Q28395641-AD9E77BC-28E7-4631-9315-8AA51BC5AC88Q28507078-0723AE9B-16B7-4EE9-B152-E736D732B768Q28543435-0374399D-CAD2-4D94-B8EC-C03F6413D3DCQ28545009-86B00200-718B-40D7-9736-7205D6AAECA1Q33575690-8DCDED12-6B4D-4134-A56E-FE34FCB51D01Q33641296-2FF9097F-F31C-40F7-BD6F-168166EA5335Q33645497-A6655CFC-EB86-43AB-A7DF-0E371625FC93Q33713310-F256999F-6DD3-4CE1-8E9A-01C05035D7EFQ33939951-0FAA6670-B4E7-4F03-88BF-FBE4B74D67A5Q33970540-257E04E9-D77E-4381-AF2A-5426A876AEE6Q33983503-F4A88ED3-27B0-43B7-BF9F-4FE30502C8CAQ34124109-9530F743-240B-40C1-9BF4-5C59269602AEQ34289003-18074FD0-CFF1-416A-BCFE-99232757E275Q34341268-7B57E24A-722A-4655-851A-D730EE0ADEEDQ34398472-BED4DF55-1477-46AD-8B78-C36627DCE199Q34517865-63B165F3-054D-4D34-872C-C48B871C6212Q34535918-C74C4F58-31F3-4D89-AB44-350ADADFBC28Q34634682-A04556F0-D534-4CDC-96A5-0FC722E891BAQ34974831-E6363BBF-F698-4497-AF73-C5117D688AACQ34979691-2AB0A1E0-2348-4FA4-BC8D-559AC19C93EDQ35001318-5B164916-1088-44C7-AE32-AF54914529D3Q35041508-A86E4B34-633A-4500-AAA1-53929C474A9AQ35227185-8750A293-F22A-44DF-96A3-DB7A5154F980Q35283173-CAF3C42F-D7CB-4297-839D-033A8B05D82DQ35512908-7B606CC2-E88A-4A2D-982D-C67829B38E53Q35753567-D3ABEE4E-3D72-4D5A-8694-19CC7C4FE3FEQ35804051-459AE342-0ADD-4496-B70A-10C9B4C61A38Q35903188-2D035F75-6112-4149-BBF4-99B86012E32B
P2860
Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic versus chemoprotective ...... and triterpenoid-treated mice.
@en
Genetic versus chemoprotective ...... and triterpenoid-treated mice.
@nl
type
label
Genetic versus chemoprotective ...... and triterpenoid-treated mice.
@en
Genetic versus chemoprotective ...... and triterpenoid-treated mice.
@nl
prefLabel
Genetic versus chemoprotective ...... and triterpenoid-treated mice.
@en
Genetic versus chemoprotective ...... and triterpenoid-treated mice.
@nl
P2093
P2860
P356
P1433
P1476
Genetic versus chemoprotective ...... and triterpenoid-treated mice
@en
P2093
Charlotte R Williams
Colin C McCulloch
Jay B Silkworth
Keiko Taguchi
Masayuki Yamamoto
Melinda S Yates
Michael B Sporn
Patrick M Dolan
Quynh T Tran
Soona Shin
P2860
P304
P356
10.1093/CARCIN/BGP100
P407
P50
P577
2009-04-21T00:00:00Z